Visceral leishmaniasis with cutaneous symptoms in a patient treated with infliximab followed by fatal consequences
Language English Country United States Media print-electronic
Document type Case Reports, Journal Article, Research Support, Non-U.S. Gov't
PubMed
24903470
DOI
10.1111/dth.12083
Knihovny.cz E-resources
- Keywords
- immunosuppression, skin manifestation, visceral leishmaniasis,
- MeSH
- Anti-Inflammatory Agents adverse effects MeSH
- Antiprotozoal Agents adverse effects MeSH
- Crohn Disease diagnosis drug therapy immunology MeSH
- Adult MeSH
- Fatal Outcome MeSH
- Gastrointestinal Agents adverse effects MeSH
- Immunocompromised Host MeSH
- Infliximab MeSH
- Leishmaniasis, Cutaneous chemically induced diagnosis drug therapy immunology parasitology MeSH
- Leishmaniasis, Visceral chemically induced diagnosis drug therapy immunology parasitology MeSH
- Humans MeSH
- Meglumine Antimoniate MeSH
- Meglumine adverse effects MeSH
- Antibodies, Monoclonal adverse effects MeSH
- Organometallic Compounds adverse effects MeSH
- Arrhythmias, Cardiac chemically induced MeSH
- Check Tag
- Adult MeSH
- Humans MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Anti-Inflammatory Agents MeSH
- Antiprotozoal Agents MeSH
- Gastrointestinal Agents MeSH
- Infliximab MeSH
- Meglumine Antimoniate MeSH
- Meglumine MeSH
- Antibodies, Monoclonal MeSH
- Organometallic Compounds MeSH
Leishmaniasis is an infectious disease caused by parasitic flagellates of the genus Leishmania. The authors present a case of 44-year-old man with Crohn's disease treated successfully with infliximab. This case report shows rare visceral leishmaniasis with cutaneous symptoms in an immunocompromised patient. Skin manifestations may occur before or after the visceral infection and they are often diverse.
References provided by Crossref.org
